Podcasts about mckesson

How do you lead organizational transformation when AI is moving faster than your roadmap can keep up?   Carlie Bissler, a product leader at McKesson, breaks down what it takes to guide large enterprises through change in the age of AI. From building trust and authenticity as a leader to shifting from "change management" to "change leadership," Carlie shares pragmatic advice for preparing your teams — and yourself — for the unknown.   She also gets real about fear in the workplace, the shame some still feel about using AI tools, and why the best CX transformations start on the inside. If you're navigating the messy middle of enterprise innovation, this episode is your blueprint for embracing agility, empowering your people, and staying human in an increasingly automated world. Key Moments:   00:00 Change Leadership, Innovation, and AI04:46 Who is Carlie Bislser of McKesson?06:13 The Role of Psychology in Leadership14:20 Navigating Organizational Transformation18:33 Embracing AI and Building Trust29:12 The Growing Fear of AI in the Workplace34:32 The Shift from AI as a Cost Center to an Asset38:03 Mentorship and Community43:13 Preparing for AI-Driven Transformation45:43 The Human Touch in Customer Experience50:57 Lightning Round: Quick Insights & Advice –Are your teams facing growing demands? Join CX leaders transforming their AI strategy with Agentforce. Start achieving your ambitious goals. Visit salesforce.com/agentforce Mission.org is a media studio producing content alongside world-class clients. Learn more at mission.org

Joe DePinto, MBA, Head of Cell, Gene & Advanced Therapies at McKesson, joins the show to discuss InspiroGene, McKesson's end-to-end platform built to address the complex delivery, coordination, and commercialization needs of cell and gene therapies. He breaks down how InspiroGene integrates logistics, specialty pharmacy, patient support services, and real-time data tracking to close critical gaps in the CGT ecosystem—especially around why many eligible patients are still not being identified, referred, or treated. He also explores the broader vision: enabling scalable access to these therapies as they move from rare diseases to larger populations, and what it will take—from providers, payers, and pharma—to meet that future. Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

In this case, the court considered this issue: Does the Hobbs Act require a federal district court to accept the Federal Communication Commission's legal interpretation of the Telephone Consumer Protection Act?The case was decided on June 20, 2025.The Supreme Court held that the Hobbs Act does not preclude judicial review of an agency's statutory interpretation in district court enforcement proceedings, and district courts must independently determine whether the agency's interpretation is correct under ordinary principles of statutory interpretation. Justice Brett Kavanaugh authored the 6-3 majority opinion of the Court.Courts may grant pre-enforcement review of agency orders through three types of statutes: those that expressly preclude subsequent judicial review in enforcement proceedings (like the Clean Water Act), those that expressly authorize review in both contexts, and those that remain silent on enforcement proceedings (like the Hobbs Act). The Hobbs Act falls into the third category, which triggers a default rule allowing district courts to independently assess agency interpretations. The Administrative Procedure Act codifies this presumption of judicial review, stating that “agency action is subject to judicial review in civil or criminal proceedings for judicial enforcement” unless prior review was adequate and exclusive. The phrase “determine the validity” in the Hobbs Act refers specifically to entering declaratory judgments in pre-enforcement proceedings, not to the broader process of evaluating an agency interpretation's correctness in enforcement actions.The Emergency Price Control Act precedent from Yakus v United States does not control because that wartime statute contained two provisions working together: exclusive jurisdiction language plus an express prohibition against other courts considering validity. Congress chose not to include this second, prohibitive provision when enacting the Hobbs Act six years later, demonstrating its intent not to preclude enforcement-stage review. Practical concerns about potential court disagreements do not override statutory text and administrative law principles, as circuit splits followed by Supreme Court review represent the ordinary judicial process. Requiring all potentially affected parties to challenge every agency order within 60 days or lose their rights would be impractical and unfair, particularly for entities that did not exist when orders issued or had no reason to anticipate future enforcement proceedings.Justice Elena Kagan authored a dissenting opinion, joined by Justices Sonia Sotomayor and Ketanji Brown Jackson, arguing that the Hobbs Act's grant of “exclusive jurisdiction” to appellate courts to “determine the validity” of agency orders plainly precludes district courts from making such determinations in enforcement proceedings.The opinion is presented here in its entirety, but with citations omitted. If you appreciate this episode, please subscribe. Thank you.

In this episode, we sit down with Dr. Prateek Bhatia, Vice President & GM at Intrafusion by McKesson, to uncover his inspiring journey from being a pharmacy student in Pune, India to leading one of the most crucial verticals in the U.S. healthcare system. What you'll learn:– Key trends shaping the infusion therapy market – The biggest challenge health systems face today – Why infusion services are a critical part of modern care – Can India become the next big hub for infusion startups? – A rapid-fire round with fresh insights and fun!This is a must-watch for pharmacy students, young professionals, and anyone curious about global healthcare leadership and innovation.Stay tuned with us!Don't forget to like, comment, and subscribe for more insights on innovation and disruption in healthcare.#Gameofpharma #pharmapodcast #infusionindustry #pharmaindustryAvailable on YouTube, Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts. Dr. Prateek's LinkedIn: https://www.linkedin.com/in/prateek-bhatia/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/

Are you tired of inventory headaches draining your time, cash flow, and team morale? In this episode of Independent Insights, we're cracking the code on an often overlooked yet powerful tool in your pharmacy: inventory management.Join host Suzanne Feeney and special guest Britney Woods, Pharmacist in Charge at a Dallas-based McKesson-owned Health Mart, as they reveal how small, strategic changes in inventory can lead to big wins for your pharmacy's bottom line—and your patients' health. You'll discover:How to turn inventory from a back-office burden into a front-line advantage.Real-world strategies to reduce dead stock, avoid costly expirations, and optimize cash flow.The power of team buy-in and how to empower your technicians to take ownership.Why med sync and just-in-time ordering are game changers for both workflow and patient care.Tools and tech that take the guesswork out of inventory—and give you back your time.Whether you're a seasoned pharmacy owner or a technician looking to level up, this episode is packed with actionable insights to help you streamline operations, boost efficiency, and strengthen patient relationships.Don't miss this behind-the-counter look at how smarter inventory can transform your pharmacy from the inside out.HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson, Health MartGuestsBritney Woods, PharmDPharmacist in Charge Dallas-based McKesson-owned Health Mart ResourcesTune into Episode 11: Maximizing Operations Through Proactive WorkflowHealth Mart Pharmacies can access Health Mart University (HMU) for:  Helpful CE courses and more on inventory management and med syncHealth Mart pharmacists to claim their CE credit for weekly GameChangers episodes   Learn more about McKesson's Pinpoint Community Solutions here: https://my.healthmart.com/purchasing/pinpoint-community-solutions The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

Doug & Dan are getting ready to head to the Big Apple on this week's episode of The Hype! But before they get set for Fanatics Fest 2025, the guys react to the surprising move that sent Red Sox slugger Rafael Devers to the Giants and breifly take a look at his Bowman market. Plus the guys discuss if Shohei's return to the mound be a good or bad thing for his career & collectibility and preview all the events going down at this year's Fanatics Fest in New York. Then Cody talks to Topps sketch card artist Ian McKesson about his recent work in Topps Series 2 Baseball and how it feels to have his work featured in upcoming Disney sets. Plus Ian takes us behind the scenes to show how he chooses what subjects to sketch and gives us a look at some of his exclusive artist proof cards! Watch this episode on our Mojobreak Media YouTube channel! Check out box breaks, interviews and more on our Mojobreak Media YouTube channel and subscribe today. Go to Mojobreak.com to get a spot in breaks of 2025 Topps Chrome Marvel & more! Visit our shop in Santa Clara or order online at mojobreakshop.com

In this episode, we sit down with Dr. Prateek Bhatia, Vice President & GM at Intrafusion by McKesson, to uncover his inspiring journey from being a pharmacy student in Pune, India to leading one of the most crucial verticals in the U.S. healthcare system. What you'll learn:– His real-life journey from B.Pharm to VP at McKesson– Why he chose pharmacy and what kept him going– The evolving trend of pharmacy grads moving abroad– Key differences in work culture: India vs the U.S.– Insights into the infusion and specialty pharmacy industry– His leadership learnings and advice for the next generationThis is a must-watch for pharmacy students, young professionals, and anyone curious about global healthcare leadership and innovation. Stay tuned for Part 2—where we dive deeper into the infusion industry!Don't forget to like, comment, and subscribe for more insights on innovation and disruption in healthcare.#Gameofpharma #globalpharmacareer #pharmawarriors #indianpharma #pharmapodcast Available on YouTube, Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts. Dr. Prateek's LinkedIn: https://www.linkedin.com/in/prateek-bhatia/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/

Roberto Moro, de robertomoro.com, y Jorge del Canto, de delcanto.es, repasan los títulos de Solaria, Acciona, Banco Santander o McKesson

Roberto Moro, de robertomoro.com, y Jorge del Canto, de delcanto.es, repasan los títulos de Solaria, Acciona, Banco Santander o McKesson

Whether you're looking for innovative ideas or practical tips, this episode offers valuable insights for a thriving front end. Gain expert insights from Megan Baccam, Director, Product Management at McKesson, and Russell Gong, Co-founder of Cabinet Health. Listeners will discover how independent pharmacies can leverage private-label products to boost patient care and business growth in this episode of Independent Insights. This episode dives into Foster & Thrive, McKesson's over-the-counter private brand. Learn actionable strategies for improving margins, attracting new customers, and enhancing your front-end growth. HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson, Health MartGuestsVanessa Thompson, PharmDSr. Manager, MarketingMcKesson, Health Mart Megan BaccamDirector, Product ManagementMcKessonRussell GongCo-Founder Cabinet HealthResources Health Mart Pharmacies can learn more about Foster and Thrive at https://www.fosterandthrive.com/ and Front End Insights at my.healthmart.com/purchasing/front-end-insightsEpisode 7: Marketing Mastery: Transform Your Pharmacy with Proven Strategieshttps://podcasts.apple.com/us/podcast/episode-7-marketing-mastery-transform-your-pharmacy/id1753117895?i=1000678415339The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

Sujatha Sivarajah ( @sujatha_sivarajah ) is the Vice President of Strategic Execution & Operational Excellence for McKesson Canada ( @mckessoncanada ).She joins Ara on this week's episode of #TheTamilCreator to discuss the significant impact of her parents while she was growing up, being a part of a graduating class that comprised only 10% females, building teams at multiple companies including LifeLabs and Sanofi, being a woman of colour in a male-dominated field, the importance of building a solid foundation, her fascination with history, and so much more.Follow Sujatha:- LinkedIn (https://www.linkedin.com/in/sujatha-sivarajah-p-eng-80897a9/)   Timestamps00:19 - Ara introduces this week's guest, Sujatha Sivarajah00:43 - Sujatha speaks on her upbringing; Jaffna, Ohio, Nigeria02:19 - Sujatha's dad being her mentor; advice for parents06:08 - Being a woman of colour in a male-dominated field (Electrical Engineering)9:52 - Her time at Ford during a recession in Canada; and then LifeLabs17:11 - Leaving LifeLabs after 7 years to build another team; this time at Sanofi21:10 - What is pharmaceutical manufacturing?22:23 - Was the lack of pharmaceutical manufacturing during the pandemic true?24:17 - What McKesson does, and what her role here is26:13 - What Sujatha hopes to accomplish during her tenure at McKesson27:34 - Her view on work-life balance29:19 - Parkinson's Law - work expands to the time allotted for it30:35 - How she secured her roles; never saying “no”40:24 - What she would have done in another life; anthropology or archaeology42:13 - Advice she would give her 16-year-old self44:02 - The legacy she wants to be remembered for by friends and family45:25 - Creator Confessions53:19 - The Wrap Up Intro MusicProduced And Mixed By:- The Tamil Creator- YanchanWritten By:- Aravinthan Ehamparam- Yanchan Rajmohan     Support the show

In the 5th episode of the “5 Pillars of Wound Care” series, Heather Trumm, Partner Account Manager with VGM & Associates, and Amanda Smithey, Senior Manager, Advocacy and Strategic Partnerships, HME Division with McKesson, explore strategies for building your referral network using your existing referral base and patient population. The episode also covers setting expectations with referral sources and offers tips on keeping them accountable to the rules and regulations you've established. Additionally, Heather and Amanda provide insights into training your referral sources, including conducting in-services, what topics to cover, and how to creatively approach training and education.Tune in to learn how to strengthen your referral network and enhance your wound care program!

Join us for an inspiring episode of the Independent Insights series by McKesson / Health Mart, where we delve into the transformative power of partnerships in the world of independent pharmacies. Hosted by Suzanne Feeney, this episode features insightful conversations with Helen Ianniello and Ellie Geise, two remarkable women who share their journeys and the pivotal role partnerships have played in success.Episode HighlightsIndependent Pharmacies provide personalized care in the communities they serve. This episode dives into how partnerships can enhance services and impact community health and well-being.In this episode you'll hear from Helen Ianniello and Ellie Giese about the power of partnerships within pharmacy. Growing up in a small town in Nebraska, Ellie was inspired by her mother's independent pharmacy. Now a Pharmacy Sales Consultant, she shares her passion for small-town pharmacies and their vital role in community health.Helen's story is one of resilience and determination. From a nurse to a successful pharmacy owner, she discusses the challenges and triumphs of taking over Stockmen's Drug and the essential partnerships that helped her turn the business around.Tune in to hear these compelling stories and gain valuable insights on how partnerships can drive success in independent pharmacies. HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson, Health MartGuestsHelen Ianniello, RNPharmacy OwnerStockmen's DrugEllie GeisePharmacy Sales ConsultantMcKesson ResourcesHealth Mart Pharmacies can learn more about APhA Project Impact opportunities by reaching out to their McKesson Pharmacy Sales Consultant (PSC) or Vice President, Pharmacy Retail Operations. The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

In the 4th episode of the “5 Pillars of Wound Care” series, Heather Trumm, Partner Account Manager with VGM & Associates, and Amanda Smithey, Senior Manager, Advocacy and Strategic Partnerships, HME Division with McKesson, delve into the essential training for HME staff in wound care. This episode covers what a comprehensive training program would entail for both your referral sources and internal staff. Key topics include disease state training, product category training, and referral and patient engagement training. Gain insights into the importance of clinical training, wound terminology, product category training for your HME staff, and the distinct training needs for sales/marketing teams and resupply staff. ResourceThe Wound Care Manual is exclusively available to VGM members on our members-only portal.

More Top Sustainable Stocks To Consider includes several articles featuring terrific renewable energy, healthcare, branded consumer and natural food stocks. By Ron Robins, MBA Transcript & Links, Episode 152, April 18, 2025 Hello, Ron Robins here. Welcome to my podcast episode 152, published April 18, 2025, titled “More Top Sustainable Stocks To Consider.” It's presented by Investing for the Soul. Investingforthesoul.com is your site for vital global ethical and sustainable investing mentoring, news, commentary, information, and resources. Remember that you can find a full transcript and links to content, including stock symbols and bonus material, on this episode's podcast page at investingforthesoul.com/podcasts. Also, a reminder. I do not evaluate any of the stocks or funds mentioned in these podcasts, and I don't receive any compensation from anyone covered in these podcasts. Furthermore, I will reveal any investments I have in the investments mentioned herein. Additionally, quotes about individual companies are brief. Please visit the podcast's webpage for links to the articles and additional company and stock information. ------------------------------------------------------------- More Top Sustainable Stocks To Consider (1) Now, the following articles offer some interesting investment ideas. The first article is titled ESG Still Matters. 3 Defensive Stocks That Make the Grade. It's by Teresa Rivas and seen on barrons.com. Here are a few quotes from her article. “Portfolio manager Bill Davis is shutting out all the noise and sticking to his guns. The term ESG has been a lightning rod for a long time, but it is—and always has been—simply ‘a proxy for finding a well managed company…' Davis puts his money where his mouth when it comes to the actively managed Hennessy Stance ESG ETF, which doesn't invest in tobacco, fossil fuel, weapons, and similar areas. He does make exceptions based on company principles. The fund uses an algorithm to rank S&P 500 companies by various risk factors and metrics, and identifies those most likely to generate positive alpha and minimize harm. It also helps avoid being reactionary to the zigzags of U.S. policy these days. That strategy, which also avoids large positions, hasn't distinguished itself in these past few years when the Magnificent Seven tech stocks and a handful of other megacaps drove index performance—the fund, though, does have positions in Google, Apple, and Netflix. Still, Davis stands firm. The strategy can show its worth when investors are more concerned with downside risk protection. There are plenty of companies, though, that Davis feels differently about. He likes drug distributor  Cardinal Health CAH —peer to Barron's pick McKesson—because healthcare remains a safe haven and Cardinal has done particularly well—doubling the S&P 500 in recent years. Its earnings growth profile is good and ‘it's a solid company with large enough scale to have pricing power.' Also making the cut is Atmos Energy AIO Davis cites the natural-gas utility's relative momentum—the shares are up nearly 30% in the past year—and its defensive qualities. Although the fund shies away from fossil fuels, distributors like Atmos that are transparent, focused on reducing greenhouse gas emissions, do fit the bill. Davis owns staple General Mills GIS as well, again for its defensive qualities, including a 4% yield, and its size—big enough to exert pricing power. He does see only modest upside, but also ‘low downside, so it's a good fit for our portfolio.'” End quotes. ------------------------------------------------------------- More Top Sustainable Stocks To Consider (2) This second article brings us back to the most likely favourite sector for ethical and sustainable investors. Its title is 5 Renewable Energy Stocks to Buy Amid Growing Market Demand by Nalak Das at Zacks and seen on finance.yahoo.com. Here's some of what Mr. Das says about his picks. “These five renewable stocks have strong long-term potential. These stocks have seen positive earnings estimate revisions in the last 60 days. Each of our picks currently carries a Zacks Rank #2 (Buy). At the same time, these companies pay dividends regularly at an attractive rate. 1. The AES Corp. AES is one of the forerunners in the utility industry's transition to clean energy by investing in sustainable growth and innovative solutions while delivering superior results. AES continues to invest in clean energy projects. In 2024, AES completed the construction of 3 gigawatts (GW) of wind, solar, gas and energy storage. [The company] expects to add a total of 3.2 GW of new renewables to its operating portfolio by the end of 2025… AES has an expected revenue and earnings growth rate of 3.1% and -1.4%, respectively, for the current year… AES has a current dividend yield of 6.32%. The AES Corporation (AES): Free Stock Analysis Report. 2. OGE Energy Corp. OGE has been investing steadily to expand its renewable generation assets. The company is focused on reducing its carbon dioxide emissions to 50-52% by 2030. As of Dec. 31, 2024, OGE owned the 120 megawatts (MW) Centennial, 101 MW OU Spirit and 228 MW Crossroads wind farms. It also owns and operates six solar sites across the state of Oklahoma and one in Arkansas, which comes with a cumulative generation capacity of 32.2 MW… OGE has an expected revenue and earnings growth rate of 0.8% and 3.7%, respectively, for the current year… [The company] has a current dividend yield of 3.88%. OGE Energy Corporation (OGE): Free Stock Analysis Report. 3. WEC Energy Group Inc. WEC is investing in cost-effective zero-carbon generation like solar and wind. During 2025-2029, WEC plans to invest $28 billion, out of which $9.1 billion will be invested in regulated renewable projects. The idea is to further strengthen WEC's renewable portfolio… WEC Energy Group has an expected revenue and earnings growth rate of 9.2% and 8.5%, respectively, for the current year…[It] has a current dividend yield of 3.42%. WEC Energy Group, Inc. (WEC): Free Stock Analysis Report. 4. NiSource Inc. NI expects to invest $19.4 billion during 2025-2029 to modernize infrastructure, which will enhance the reliability of its operations. NISource continues to add clean assets to its portfolio and retire coal-based units. [The company] is set to retire its 100% coal-generating sources between 2026 and 2028 and replace the production volumes with reliable and cleaner options at lower costs. NISource aims to reduce greenhouse gas emissions by 90% by 2030 from the 2005 levels. This initiative can help NISource lower the cost of operations by focusing on new and advanced assets. New products and services can lead to added revenue streams… NiSource has expected revenue and earnings growth rates of 11.1% and 6.9%, respectively, for the current year… [it] has a current dividend yield of 2.94%. NiSource, Inc (NI): Free Stock Analysis Report. 5. CMS Energy Corp. CMS remains one of the primary utility providers in Michigan. CMS plans to invest $20 billion in infrastructure upgrades, repair and clean energy generation during 2025-2029. In November 2024, CMS filed its 20-year renewable energy plan, which includes the addition of nine GW of solar and four GW of wind to its generation portfolio during 2025-2045… CMS Energy has an expected revenue and earnings growth rate of 7.4% and 7.8%, respectively, for the current year… [it] has a current dividend yield of 3.05%. CMS Energy Corporation (CMS): Free Stock Analysis Report.” End quotes. ------------------------------------------------------------- More Top Sustainable Stocks To Consider (3) This third article is an updated version of a February 20, 2025, story. It was featured in my Podcast: The Low-Carbon Stocks for Sustainable Investors. Its new title is Best Natural and Organic Food Stocks to Buy Now in 2025 by Sumit Singh. Again, it's from the great Zacks research group and found on finance.yahoo.com. Here are some quotes from the new article. “Companies like The Hain Celestial Group, Inc. HAIN, General Mills, Inc. GIS and Vital Farms, Inc. VITL are responding to the rising demand for organic, clean-label and ethically sourced foods. With consumers prioritizing transparency, sustainability and minimal processing, the market for natural foods continues to grow. Expanding farm networks, plant-based innovations and a focus on humane, eco-friendly production are shaping the industry's future… The global healthy foods market is expected to reach $2.26 trillion by 2035. 3 Natural Food Stocks to Watch 1. United Natural Foods, Inc. UNFI stands as a prominent player in the natural food sector, serving as one of the largest distributors of organic and natural products in North America. Through its extensive network, United Natural Foods supplies a vast array of products, including fresh produce, pantry staples, dairy alternatives and plant-based foods. With its diverse portfolio, the company caters to both retail giants and independent natural food stores, meeting the growing demand for cleaner, healthier eating options. United Natural Foods has made a strategic shift by realigning its wholesale business into two product-centric divisions — one of which is solely dedicated to natural, organic, specialty and fresh products… This Zacks Rank #2 (Buy) company is increasingly focusing on innovation and sustainability within the natural foods space. The company has committed to enhancing its supply-chain practices, reducing waste and supporting regenerative agriculture initiatives. United Natural Foods is also working closely with suppliers to accelerate food innovation. Upgrades in automation and warehouse processes are leading to better order accuracy, less product waste and faster deliveries. United Natural Foods, Inc. (UNFI): Free Stock Analysis Report. 2. Sprouts Farmers Market, Inc. SFM has been at the forefront of the natural and organic food movement, catering to health-conscious consumers seeking fresh, high-quality and ethically sourced products. The company's commitment to fresh, organic and attribute-driven products sets it apart. This strategic positioning not only resonates with a growing base of wellness-focused consumers but also aligns with broader food industry trends favoring transparency, sustainability and nutritional value… In addition to product innovation, this Zacks Rank #2 company excelled at enhancing customer engagement through strategic merchandising events and effective marketing campaigns. Seasonal events like the Summer Cherry Festival shine a spotlight on fresh, specialty items and educate consumers on better-for-you choices. This approach not only drove strong traffic across its channels but also contributed to its robust e-commerce growth, surpassing $1 billion in sales in 2024. Sprouts Farmers Market, Inc. (SFM): Free Stock Analysis Report. 3. Beyond Meat, Inc. BYND has strategically realigned its product innovation to strengthen its appeal among health-conscious and natural-food-seeking consumers. A standout development in this direction is the launch of Beyond IV and the extended Beyond Steak line. These new offerings have been designed not only to deliver flavor and texture improvements but also to meet heightened consumer expectations around nutrition and ingredient transparency. These products have earned accreditations from respected health organizations, including the American Heart Association, American Diabetes Association and Clean Label Project. This Zacks Rank #2 company has taken a proactive stance, using nutritional credentials and transparent messaging to reposition its products as a better-for-you choice. By doubling down on natural and functional food innovation, the brand is not only aiming to win over skeptical customers but also elevate its products to a new standard that aligns more closely with organic and wellness-oriented trends in the food industry. Beyond Meat, Inc. (BYND): Free Stock Analysis Report. End quotes. ------------------------------------------------------------- Additional article links 1. Title: Analog Devices a Top Socially Responsible Dividend Stock With 2.2% Yield (ADI) on nasdaq.com. By BNK Invest. 2. Title: How to Invest in IonQ (IONQ) on fool.com. By Rachel Warren. 3. Title: 11 Climate-Tech Companies to Watch in 2025 on inc.com. By Chloe Aiello. UK article link Title: Triodos Bank Recognised as Top-Scoring Best Buy by Ethical Consumer on ffnews.com. By Ethical Consumer. ------------------------------------------------------------- Ending Comment These are my top news stories with their stock and fund tips for this podcast, “More Top Sustainable Stocks To Consider.” Please click the like and subscribe buttons wherever you download or listen to this podcast. That helps bring these podcasts to others like you. And please click the share buttons to share this podcast with your friends and family. Let's promote ethical and sustainable investing as a force for hope and prosperity in these troubled times! Contact me if you have any questions. Thank you for listening. I'll talk to you next on May 2nd. Bye for now.   © 2025 Ron Robins, Investing for the Soul

Send us a textThis episode was taped live at the ViVE 2025 conference in Nashville, Tennessee. About This EpisodePatty Hayward, General Manager of Healthcare and Life Sciences at TalkDesk, shares how personalized AI communication in healthcare is becoming reality. In a groundbreaking partnership with Epic, TalkDesk is transforming healthcare contact centers from cost-driven call hubs into vital parts of the care team, integrating support directly into electronic health records and empowering agents to guide patients with empathy and precision. Hayward dives into this evolution and makes a compelling case for co-innovation, challenging outdated metrics and redefining what truly human-centered healthcare can look like. Whether you're a healthcare professional, technology enthusiast, or simply someone who's experienced the frustration of healthcare bureaucracy, this episode offers a compelling vision of how bold thinking and strategic partnerships are creating more human-centered experiences. About Patty HaywardPatty Hayward, General Manager of Healthcare and Life Sciences at Talkdesk, has over a quarter century of industry strategy experience, including at organizations such as McKesson, Medicity, and Humedica. She is an expert in HIE, population health, pharmacy, process redesign for healthcare systems, and increasing access to patient information. Additional ResourcesLinkedIn: @PattyHaywardSupport the show-------- Stay Connected www.leighburgess.com Watch the episodes on YouTube Follow Leigh on Instagram: @theleighaburgess Follow Leigh on LinkedIn: @LeighBurgess Sign up for Leigh's bold newsletter

In the 3rd episode of the “5 Pillars of Wound Care” series, hosts Heather Trumm, Partner Account Manager with VGM & Associates, and Amanda Smithey, Senior Manager, Advocacy and Strategic Partnerships, HME Division with McKesson, dive into the essentials of establishing effective vendor partnerships. They explore strategies for simplifying the process of developing and identifying the right vendor relationships for your business. Heather and Amanda also discuss how to leverage the resources that vendors offer to maximize your success, and how to utilize your relationships to help generate leads together. A lot of these concepts not only work with surgical dressings, but also can apply to HME, DME, respiratory and more. 

Ford v. McKesson

In the second episode of the “5 Pillars of Wound Care” series, Heather Trumm, Partner Account Manager with VGM & Associates, and Amanda Smithey, Senior Manager, Advocacy and Strategic Partnerships, HME Division with McKesson, return to delve into the development of your surgical dressings program. They cover essential components such as the Surgical Dressings LCD, the importance of formulary development, and the order process, including the resupply aspect. This may be the most crucial step of your wound care program development- you won't want to miss this episode!

Join Suzanne Feeney from McKesson Health Mart and guest Josh Borer, a seasoned pharmacy owner, as they explore innovative strategies to enhance pharmacy operations. Discover how synchronizing refills and scheduling patient appointments can revolutionize your pharmacy practice, reduce costs, and improve patient outcomes. Tune in for practical tips and inspiring stories from the frontlines of independent pharmacy. HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson, Health MartGuestsJosh Borer, PharmDPresident/OwnerRex PharmacyResourcesHealth Mart Pharmacies can access Health Mart University (HMU) for:Helpful CE courses and more on inventory management and med syncHealth Mart pharmacists to claim their CE credit for weekly GameChangers episodes The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

This episode of the Industry Matters Podcast is the first in a five-part series, the Five Pillars of Wound Care: Identify Market Needs. Join industry experts, Heather Trumm, Partner Account Manager with VGM & Associates, and Amanda Smithey, Senior Manager, Advocacy and Strategic Partnerships, HME Division with McKesson, as they discuss how to determine if the wound care market is right for your business, the industry landscape, profitability, and more.  Resources:Wound Care Guide: Determine if the wound care category is right for your businessWound Care Manual: Comprehensive manual on the wound care industry including, an introduction to the industry, product overview, setting up a marketing plan, and additional resourcesVGM Market Data: See who's billing for wound care HCPCS codes or where those referrals are going

Join us for an exciting episode of Independent Insights as Suzanne Feeney sits down with Dr. Elizabeth Skoy from North Dakota State University. They delve into the dynamic transformation of community pharmacists' roles and explore the power of collaborative practice agreements and test-to-treat services. These innovations are opening new doors for pharmacists to make a significant impact in their communities. From empowering pharmacy technicians to embracing a team-based care approach, this episode is brimming with actionable insights and strategies designed to inspire you to lead the charge in pharmacy practice transformation within your state. Whether you're a seasoned pharmacist or just starting your journey, this episode offers valuable guidance on enhancing your pharmacy's influence while keeping patient care at the forefront. Tune in and discover how you can drive positive change and elevate the standard of care in your community pharmacy!HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson / Health MartGuestElizabeth Skoy, PharmD, FAPhAProfessor and Director of the Center for Collaboration and Advancement in PharmacyNorth Dakota State UniversityResourcesHealth Mart franchise members can access Health Mart University for point-of-care testing, Test-to-Treat, and compliance courses here: Health Mart UniversityThe views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

This week on Geek Off The Street, we're talking about Captain America: Brave New World with our friend Wilbur Mckesson III! We talk about the characters and the action and pacing but also the lackluster story and also why this movie has such huge backlash! All that and so much more on this week's exciting episode of the GOTS Official Podcast!Podcast Timecodes![1:45] What are we drinking this week?[2:30] Fantastic Four Trailer Discussion[14:40] Opening Thoughts and Facts[18:35] Positives[33:35] Negatives[59:30] Rating[1:02:50] What Are We Into This Week?Check Out These Books! When The Sakura Blooms! by J. Leroy Tucker!Wilbur Mckesson's Retribution!Greg Sorber's Mechhaven!Pax Machina Audio Book!Join Us In The Discussion!Email: thegeeksoffthestreet@gmail.comInstagram: @thegotspodSubscribe on Youtube!Like Our Facebook! Twitter: @thegotspodTrent Personal: @trentctuckerMusic: @erictucker__Stuff We Mentioned!Chikara Ramen!Trent Tucker Vlogs!Invincible Season 3!House of Cards!               Dr. Stone!People We Mentioned!Tree of Dreams Music@chikara_ramen@badicalradness@jenjoink@gregerationx@author_wilbur_m@mcpodcast@z_daughter_of_light@mindmattermystery

In this premiere episode, Jessica White, PharmD, VP of Speciality Portfolio & Programs at McKesson, brings over 20 years of experience to the table. From managing oncology's generics portfolio to fostering manufacturer relationships, Jessica shares her unique insights into the strategies that can help navigate drug shortages and ensure continuity in patient care.Tune in as Jessica emphasizes the importance of collaboration among stakeholders to maintain supply chain stability and deliver exceptional care.Check out Jessica's article, Stakeholders Collaborate to Ensure Supply Chain Continuity, where she discusses how effective collaboration can help prevent drug shortages and maintain continuous patient care.

What if scheduling a doctor's appointment was as easy as booking a table at your favorite restaurant? Join for an enlightening discussion with Jeff Gartland, CEO of Relatient, as we unlock the complexities of patient scheduling in healthcare. Jeff shares his unique perspective, drawing from a childhood influenced by behavioral psychologists and a career spanning top healthcare technology firms like McKesson, Ciox, and Elevance. Together, we explore how patient scheduling is much more than a tech challenge; it's about transforming human interactions in healthcare. From understanding the nuances between "new" and "existing" patients to creating a seamless, consumer-centric referral system, Jeff offers invaluable insights into reshaping the way we engage with medical practices.Discover how cutting-edge technology can bridge the gap in appointment scheduling while boosting  patient access and satisfaction. Jeff explains the paradox of how long waits for appointments can coexist with underutilized clinical time, offering solutions that hinge on sophisticated scheduling systems and automated waitlists. We discuss the significance of a portal-free experience that simplifies the referral process and enhances convenience for patients. Whether it's aligning scheduling rules to meet patient demand or ensuring operational precision without sacrificing accessibility, this episode provides a roadmap to boost patient engagement for a better healthcare experience.Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

Join us for an inspiring episode of Independent Insights, where we celebrate the remarkable stories and achievements of the 2024 Health Mart Pharmacy of the Year Award finalists.  Delve into the vibrant world of independent pharmacies as we explore the innovative strategies and community-driven efforts of these pharmacy powerhouses. Hear from finalists Avery Drier of Drier Pharmacy, Jennifer Metcalf of Hayden Pharmacy, and Brian Marr of Creswell Pharmacy, who share their secrets to success, from creative branding and engaging community events to savvy business practices and advocacy. Don't miss out on hearing firsthand accounts of resilience, dedication, and the collective push for industry progress. And remember to mark your calendars for the McKesson ideaShare event in Nashville, Tennessee, from July 10th to 13th, 2025, where you can connect with fellow pharmacists and explore new horizons in independent pharmacy.HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson, Health MartGuestsVanessa Brown, PharmDSenior Manager, MarketingMcKesson / Health MartAvery DrierStudent PharmacistDrier PharmacyJennifer MetcalfPharmacistHayden PharmacyBrian MarrPharmacistCreswell PharmacyResources Health Mart Pharmacies can learn more about the Health Mart Pharmacy of the Year Award here: https://mckessonideashare.com/health-mart-pharmacy-of-the-year/Applications for the 2025 Health Mart Pharmacy of the Year Aware will open on February 1st, 2025 and close on March 1st, 2025.  The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

Administrative Law: Does the Hobbs Act require district courts to accept the FCC's legal interpretation of the Telephone Consumer Protection Act? - Argued: Tue, 21 Jan 2025 14:35:35 EDT

McLaughlin Chiropractic Assoc. v. McKesson Corp. | 01/21/25 | Docket #: 23-1226

Judge Aileen Cannon is popping off, the Alex Jones bankruptcy continues to be crazy, and judges in Arkansas are going to war with each other. Plus, as always, we'll check in with our pal Rudy.   Links: Alex Jones - TX Plaintiffs settlement https://storage.courtlistener.com/recap/gov.uscourts.txsb.459750/gov.uscourts.txsb.459750.1011.0.pdf   McKesson v. Arkansas complaint https://www.documentcloud.org/documents/3671323-McKesson-Complaint/   Baker Jan. 1 appointment orders https://arkansasadvocate.com/wp-content/uploads/2025/01/Appointment-Orders.pdf   Arkansas Administrative Order 24 https://opinions.arcourts.gov/ark/supremecourt/en/item/523224/index.do   Arkansas Supreme Court per curiam opinion 1/6/25 https://opinions.arcourts.gov/ark/supremecourt/en/item/523226/index.do   “Order of Chief Justice,” 2025 Ark. 4 https://opinions.arcourts.gov/ark/supremecourt/en/item/523231/index.do   Trump emergency motion to block release of Smith Report https://storage.courtlistener.com/recap/gov.uscourts.flsd.648652/gov.uscourts.flsd.648652.700.0_1.pdf   Giuliani NY docket https://storage.courtlistener.com/recap/gov.uscourts.nysd.627518/ Show Links: https://www.lawandchaospod.com/ BlueSky: @LawAndChaosPod Threads: @LawAndChaosPod Twitter: @LawAndChaosPod Patreon: patreon.com/LawAndChaosPod  

In this episode of Money Tales, our guest is Sara Eversden. Sara grew up in a neighborhood where labels like 'the lower-income side of town' were casually tossed around. But for her, it wasn't about what her family didn't have, it was about what they gained. In a community rich with diversity, both socioeconomically and racially, Sara developed a deep comfort and appreciation for being in all kinds of environments. That early exposure shaped how she navigates the world today, including her relationship with money and identity. Sara Eversden is a leader in healthcare finance, and operations with over two decades of experience driving success for physician organizations and medical groups across the U.S. As a Certified Public Accountant (CPA) with a master's in healthcare administration, Sara has a proven track record of optimizing organizational performance, transforming complex organizations, and leading high-performing teams. Currently serving as Senior Vice President of Women & Children's Operations at Envision Healthcare, Sara manages a multi-state portfolio spanning 15 states, 70 hospitals, and 500+ clinicians. Previously, Sara held pivotal roles such as Market President & CEO at Women's Health USA, where she integrated multiple practices post-acquisition, and as a CFO within McKesson's US Oncology Network, where she spearheaded financial strategies for Network practices. Sara's expertise spans startups, turnarounds, post-merger integrations, and complex reorganizations, making her uniquely positioned to navigate challenging healthcare environments. Beyond her professional accomplishments, Sara is passionate about empowering the next generation of leaders through education and service. She is a former board member at the National Charity League and co-founded a nonprofit aimed at providing college scholarships to high school graduates from underserved populations. A four-time participant in the Phoenix Rock ‘n' Roll Half Marathon, Sara is also an avid adventurer, having completed the Grand Canyon Rim-to-Rim trek three times.

For our final Engineering spotlight this month, I sit down with Brent Wunderlich. Brent Wunderlich is an experienced people leader with a proven track record in optimizing healthcare supply chain operations. He has been with McKesson Corporation for 22 years, currently serving as Vice President of Strategic Initiatives & Insights.  Brent collaborates with internal and external partners to drive large-scale projects and strategic initiatives. With a background in engineering and analytics, Brent leverages data to improve supply chain performance and has held various leadership roles within McKesson.  He holds a B.S. in Industrial Engineering from Purdue University.  Brent is also actively involved in community organizations, holding board positions with several local non-profit and community organizations.

In this episode, we sit down with Kyle Beyer, a seasoned pharmacist and owner of two thriving independent pharmacies. Tune in as he divulges best practices on streamlining vaccine operations, optimizing workflow, and leveraging community relationships to boost vaccination rates. Then we're joined by McKesson Health Mart pharmacist, Januari Lewis to dig into specific Health Mart resources for those of you that are Health Mart pharmacies looking to expand your vaccine services or implement a new vaccine solution in your pharmacy. Whether you're looking to start offering vaccines or enhance your current process, this episode is packed with actionable strategies to elevate your pharmacy's services.Please note that since the recording of this episode, the U.S. Health and Human Services extended the PREP Act amendments, allowing pharmacists, pharmacy interns, and pharmacy technicians to independently administer vaccines and provide test-to-treat services for COVID-19 until December 31, 2029. You can read more about this extension in the December 11th, 2024, Federal Register here: Federal Register :: 12th Amendment to Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19.  HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson / Health MartGuestsKyle Beyer, PharmD Owner / Pharmacy ManagerNorth Shore Pharmacy & Compounding CenterJanuari Lewis, PharmDSr Manager, Strategy & ImplementationMcKesson / Health MartHealth Mart franchise members can access the following resources:Immunization Resource Kit (https://my.healthmart.com/immunizationsBusiness.htm)Immunization Practice Starter (https://my.healthmart.com/immunizationsPharmacy.htm)Technician Specialist: Vaccine Coordinator Training (https://healthmartuniversity.ceimpact.com/library/course/6197)The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

Today, The Frontier Psychatrists welcomes back my friend Ben Spielberg. He's been a reader for a long time and has contributed to the newsletter in the past. It was on Clinical Trial design, a perennial favorite around these parts.With only light edits, what follows is his work, narrated by me, for the Audio Version.I would invite you to the live class today on working as an out-of-network provider, but it sold out last night, so you'll have to wait for the next one. My prior article on Spravato is available here.The year is 2024. OpenAI has just launched its latest update to ChatGPT, promising more natural and less artificial-sounding language. Donald Trump has won the nomination for President of the United States. Another chain of ketamine clinics has engaged in a corporate reorganization. There is conflict in the Middle East. Are we sure that we're not living Groundhog's Day?I am the founder of Bespoke Treatment, an integrative mental health facility with multiple locations that has at times been referred to as a "ketamine clinic." I have also seen countless so-called "ketamine clinics" sell for pennies on the dollar and go bankrupt seemingly overnight. In this case, Numinus, a company that was publicly traded in Canada and owned a number of psychiatric clinics specializing in ketamine in the US and Canada, has sold its clinics to Stella (a company that has stealthily become one of the larger mental health providers in the country and is the first to bring the awesome SGB treatment to scale). It's not the first time this has happened. It's not the second, nor the third, nor even the fourth time this has happened. But yet, the common consensus is that ketamine clinics are a cheap, easy business with recurring revenue. So, what gives?Figure 1. A reddit user asking anesthesiologists if they should start a ketamine or Botox clinic for easy cash on the side. Does this make you feel gross? Should it?The Ketamine Clinic Model 101The most basic outline for a ketamine clinic is as follows: a provider rents an office space with, on average, five or so exam rooms. They buy equipment for infusions like a pump, catheter, needles, and syringes. They buy some comfortable recliner chairs. They hire a receptionist to answer phones, field patient questions, charge credit cards, and handle medical record requests. They hire a nurse to insert the IV, monitor vital signs, check blood pressure, juggle multiple patients at once, and make sure the ketamine is flowing into patients' veins unencumbered. Two SKUs are typically offered: ketamine infusions for mood, which last approximately 40 minutes, and ketamine infusions for pain, which last for up to 4 hours. Zofran is offered for nausea, and some clinics have fun add-ons like magnesium or NAD. An average mood infusion costs around $400-$500 in a medium cost-of-living area, while mood-infusions can run up to $700 in a higher cost-of-living area. Some clinics offer package discounts if patients buy six or more upfront, which helps with cash flow for the clinic (cash now is better than cash later, of course).A Note on Scope of PracticeThe first wave of ketamine clinics was started mainly by providers who were not mental health specialists. Instead, they were owned by anesthesiologists, ER physicians, and sometimes CRNAs. These providers were especially experienced with ketamine in hospital settings, as well as setting up infusions. Psychiatrists, on the other hand, do not usually order infusions in outpatient settings, and very few had actual hands-on experience with ketamine in practice. That being said, there are a number of variations to the model above: psychiatrist-owned ketamine clinics would often prefer to use intramuscular injections in lieu of infusions, but 2-3 injections would have to be given during a single session for mood and pain sessions were out of the question. Other ways to save costs might include having an EMT do the actual injections (this is highly state-dependent), asking nurses or MAs to work the front desk, or working a full-time regular doctor job. In contrast, your nurses run the actual ketamine services via standing orders, a written document that details routine and emergent instructions for the clinic.Some clinics offer full evaluations prior to rendering treatment, but many offer a simple brief screening on the phone to check for contraindications before scheduling a patient for their first session. The clinics owned by psychiatrists have historically been a bit more thorough in terms of the initial psychiatric evaluations, given that they can actually perform initial psychiatric evaluations within their respective scope of practice. Sometimes clinics may have therapists on-site who can render ketamine assisted therapy (meaning, therapy occurring concurrently) for an additional $100-$300. Otherwise, there is not much decision-making that goes on— other than deciding on medication dosages. Most infusions start off at .5mg/kg of body weight, which is by far the most evidence-based dosage. In practice, most clinics increase dosage every session because even though ketamine is considered to be a weight-based medicine for anesthesia, there is thought to be a “sweet spot” of dosage for everyone, if one can imagine an inverted U shape curved, where the ideal dosage for each patient is at the tippity-top of the inversion. Dosage increases are highly variable depending on the clinic: some have a maximum dosage, some will only increase a certain percentage, and some may even use standardized increments (e.g., only offering dosages in increments of 50mg). A typical series of infusions is 6-8 over 3-4 weeks, followed by boosters as needed.Fool's GoldAt first glance, the business model seems fantastic. As a cash business, there are no AR issues, no third party billing companies to deal with, and no prior authorizations to fight over. Sure, the cost is high, but it's not that high compared to many other healthcare services. Since the benefits fade over time, a ketamine clinic has built-in recurring revenue from patients every week, month, quarter, or year – it's like a subscription business! Ketamine is trendy and sexy; TV shows like White Lotus mention it, and ravers from the 90's recall it with great fondness. Unlike SSRIs and psychotherapy, ketamine works for depression fast. It's amongst the fastest treatments for depression that we have today, and there are a lot of depressed people. It can help someone out of debilitating depression in 40 minutes. It has none of the un-sexy side effects of SSRIs like sexual dysfunction, gastrointestinal discomfort, or uncontrollable sweating. Instead, it has sexy side effects: euphoria, hallucinations, and feelings of unity with the universe. Also, unlike SSRIs, it helps most people who try it. It really is an amazing treatment, and I often feel grateful that my clinic is able to offer it to patients in needFigure 2. Most business-savvy reddit user.Supply and Demand… or SomethingMood disorders disproportionately affect individuals who are of lower socioeconomic status compared to individuals with a lot of disposable income. Of course, wealthier individuals are no more immune to mental health disorders than anyone else, but the main target market that benefits most from ketamine just do not have the means to afford it. They don't have $3,000 to burn on yet another treatment that may or may not work. Often, the patients who could really use a series of ketamine infusions cannot scrounge enough money for a single infusion, let alone a whole series and prn boosters. However, there should be enough depressed people with cash to throw around out there… right?Wait, Isn't That A Horse Tranquilizer?Of course, ketamine clinics can find more patients via marketing and advertising. However, I've found that many medical doctors who see this population, like primary care providers, are not up to date with the research. When I first launched my company, I used to go door-to-door to medical buildings in Santa Monica with cookies to speak with them about advancements in interventional psychiatry. I cannot count the number of times that I was laughed out of each office; referring providers are risk-averse, and the perception of ketamine has traditionally been poor. Medical doctors would exclaim, “Of course people feel better; you're getting them high,” and lament that I was administering a drug thought to be highly addictive. Psychotherapists, who would also be fantastic referral partners, generally refer to psychiatry, but it's less common for them to refer to specific treatments. Nowadays, psychotherapists who are particularly invested in ketamine can sign up with venture-backed companies like Journey Clinical and render their own ketamine-assisted psychotherapy with some prescriber supervision. The issue is that despite the media attention, people with depression don't read innovative health newsletters, nor do they review papers in scientific journals. They rely on information from their psychiatrists, medication management providers, and psychotherapists. If they are not told that this is an option for them, they won't hear about it without ad spend. Oh yeah, and there is a major issue with ad spend: the word ketamine itself is a restricted drug term, and legitimate clinics routinely get banned from Google and Meta for mentioning it, which makes digital advertising more difficult than it would be for any other legitimate service.The Matthew Perry EffectKetamine is very desirable for some patients (unfortunately, sometimes the patients who want it most are frankly the worst candidates for it), but I'd wager that the majority of patients who need it are kind of scared of it. They want to feel good, they want relief from depression and trauma, but it's a weird thing to do a drug that is a horse tranquilizer and also an anesthetic in a reclining chair in a medical office that tricks your brain into feeling like you're dead for a little bit. It's kind of far off from acupuncture and more traditional alternative medicine. There is certainly a non-zero addictive potential that needs to be carefully weighed, it's not a particularly comfortable experience for many patients—especially those with a history of trauma—even if it helps after the experience is over. Additionally, the famous actor from the most famous show in the world, who was deemed to have a cause of death relating to ketamine, isn't exactly helping mass adoption. Overall, this just makes marketing and advertising even more expensive, because a) the majority of referring providers are skeptical, b) patients can't pay for it and c) patients who can pay for it are cautious.Disruptive Business ModelsIn the model I've described above, there are 3 sets of cost centers: rent, staff, and marketing. In some areas of the country, rent may be negligible, and in others, it is quite high. Like an owner-operated restaurant, if a clinic is owned by a company that is not a clinician, they have to find one and pay for one. Venture-backed companies like Mindbloom, Better U, and Joyous have also created entire businesses on the back of the COVID-era controlled substance waivers, whereby they send patients ketamine tablets and/or lozenges directly through the mail. Unlike the clinic model, they don't have rent to pay, and since national marketing campaigns are often cheaper than hyper-local brick and mortar campaigns, they are able to find new patients at lower acquisition costs compared to their clinic counterparts. Some patients do extensive research before treatment and only want to find IV clinics that offer specific dosages, but many are fine with the cheapest ketamine possible, and would prefer to pay as low as $150 for an entire month compared to $3,000.Figure 3. Did you sign up for a discounted ketamine subscription on Black Friday after purchasing a new flat-screen TV?Spravato: Coming In HotJohnson & Johnson's branded esketamine (note the prefix es) is on track to reach coveted “blockbuster status.” While it was FDA approved for Major Depressive Disorder in 2019, it took some time to catch on for a number of reasons including skepticism that the added es only added to pharma pockets and didn't actually work, health insurance companies taking time to decide on what their medical necessity criteria should be, and social isolation due to COVID-19 being a thing. My clinic has become one of the larger Spravato providers in the Los Angeles area, and while we still offer ketamine infusions, our infusion census has decreased by over 70%. The scenario is this: a patient with severe depression comes in to see us, they've heard about ketamine, but they find out that Spravato is covered by insurance for a $20 copay. Maybe ketamine has slightly better efficacy (which, in my opinion, is really just a function of being able to adjust dosage). Still, patients would prefer paying a lot less money to receive almost-the-same benefits.Death By A Thousand SticksThere are a number of other issues with the model that become problematic, especially at scale. Large medical distributors like McKesson and Henry Shein have instituted CYA policies, limiting ketamine sales to licensed anesthesiologists. Medical malpractice carriers alike have followed suit, requesting detailed addendums from providers regarding their ketamine training or flat-out refusing coverage for anyone who isn't an anesthesiologist. Since controlled substance manufacturing is directed by the DEA based on their own predictions, it's not uncommon for ketamine to go on shortage for weeks to months at a time. There are a myriad of problems with the model of point solutions which have been detailed here already, but in short, the old adage rings true: if all you have is a hammer, everything looks like a nail, and if all you have is ketamine, everything looks like a juicy vein. But while ketamine is a highly efficacious treatment, it's not the best treatment for everyone, and patients can become downright dysregulated after ketamine, which a clinic in this model just can't handle adequately at scale. And ultimately, methods to do everything cheaper don't work out that well. For example, putting multiple patients in one room may seem like a good idea, but it is ultimately not conducive to the actual ketamine experience. Any sort of vertical integration also adds an insurmountable amount of complexity, like starting to offer Spravato or TMS, because now they have to start accepting insurance, become in-network, manage billing and AR, and so on. Depending on location and the clinic set-up, they also require specialized providers onsite.Figure 4. Supply chain issues abound.Insurance IssuesSome patients try to be well-informed. They, rightly or otherwise, don't believe everything they hear from their providers, so they call up their health insurance companies and ask. They just call the phone number on the back of the card and ask the representative if ketamine infusions are covered. Undoubtedly, the representative says yes—even though many insurance companies have published guidelines that explicitly deny any coverage for ketamine for a mental health disorder. These patients come in frustrated, distrustful of their providers and reaffirms their belief that ketamine clinics are just cash grabs. Even if one manages to obtain a coveted insurance contract for ketamine, like Ketamine Wellness Centers had with the VA, it kickstarts cashflow and complexity issues that scale should sort out, but ultimately doesn't because of the aforementioned issues above.Overall, it is possible to have a successful ketamine clinic in 2024. Still, it isn't easy due to market conditions, the population served, and the ever-changing landscape of mental health treatment. While many successful clinics exist today, the wheels tend to start to fall off when scaling, where all of a sudden, a clinic's reach has surpassed its captive population. Otherwise, it becomes a series of continual cost-cutting until there is nothing left to cut… save for the business itself.Ben Spielberg is the Founder and Chief Executive Officer of Bespoke Treatment, a comprehensive mental health facility with offices in Los Angeles, CA, and Las Vegas, NV. He is also a PhD Candidate in Cognitive Neuroscience at Maastricht University.For more on psychiatric medications, buy my book Inessential Pharmacology. (amazon link).For pieces by other TFP contributors, follow:Alex Mendelsohn, Michelle Bernabe, RN, @Psych Fox, Carlene MacMillan, MD, David Carreon, M.D., Benjamin Lippmann, DO, Awais Aftab, Courtny Hopen BSN, HNB-BC, CRRN, Leon Macfayden and many others! The Frontier Psychiatrists is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit thefrontierpsychiatrists.substack.com/subscribe

This week on Geek Off The Street, we're doing a post Thanksgiving check-in as we've both been on vacation. Trent brings Wilbur Mckesson back on the show to have a discussion about the upcoming shows Star Wars The Skeleton Crew, Creature Commandos as well as Mission Impossible Final Reckoning! Join us as we get into all that and so much more on the GOTS Official Podcast!Podcast Timecodes![5:00] What Are We Drinking This Week? [8:10] Star Wars The Skeleton Crew Trailer Discussion[32:45] Creature Commandos Trailer Discussion[45:45] Mission Impossible Final Reckoning Trailer Discussion[59:05] Everything Wilbur Is Working OnCheck Out These Books!When The Sakura Blooms! by J. Leroy Tucker!Wilbur Mckesson's Retribution!Greg Sorber's Mechhaven! Pax Machina Audio Book!Join Us In The Discussion!Email: thegeeksoffthestreet@gmail.comInstagram: @thegotspodSubscribe on Youtube! Like Our Facebook!Twitter: @thegotspodTrent Personal: @trentctuckerMusic: @erictucker__Stuff We Mentioned!Trent Tucker Vlogs!People We Mentioned!Tree of Dreams Music@chikara_ramen@badicalradness@jenjoink@gregerationx@author_wilbur_m@mcpodcast@z_daughter_of_light@mindmattermystery

Send us a textEver tried to schedule a doctor's appointment, only to be stuck on hold for what feels like forever?You're not alone. A lot of Americans feel the same frustration.Could there be a better way to take control of scheduling?In this episode of HealthBiz Briefs, Relatient CEO Jeff Gartland explains why self-scheduling is still a novel concept in medicine and how its implementation can improve patient access while increasing appointment volumes for providers.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.

Marketing isn't just another task – it's the heartbeat of your pharmacy business. Whether you're a marketing newbie or looking to refine your strategy, this episode is packed with valuable insights to help your pharmacy thrive. Join Suzanne Feeney for part 2 of our marketing series with her guests: marketing experts Kristin Rademacher and Renee Dudek as they discuss practical strategies and tips like search engine optimization (SEO), establishing your brand, budgeting, and measuring return on investment (ROI) that promise to boost patient engagement and revenue. Don't miss out on the chance to make marketing a powerful tool for your business. HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson / Health MartGuestsKristin RademacherDirector, Marketing  McKesson / Health MartRenee Dudek, MBAManager, Local MarketingMcKesson / Health MartResourcesHealth Mart franchise members can access the following resources:Marketing Edge Technician Specialist: Pharmacy Front-End Training https://healthmartuniversity.ceimpact.com/library/course/6607 ReferencesIf you haven't already, don't forget to watch Part 1 of this 2-part series on marketing: Episode 6: Pharmacy Success Secrets: Marketing for Busy Pharmacists. The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

Jared French, partner and creative director at indie agency Holden Ellis, tells Jack O'Brien why his latest campaign for wholesaler McKesson — dubbed Meet the Moment — spotlights the “grit and determination” of healthcare workers Our Trends segment breaks down president-elect Trump's latest slew of cabinet picks and what they could mean for the life sciences industry.Music by Sixième SonCheck us out at: mmm-online.comFollow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+MTo read more of the most timely, balanced and original reporting in medical marketing, subscribe here. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Drew DePriest, MCR.w, WELL AP is Director of Real Estate Operations Technology at McKesson where he is passionate about innovating in the built environment using the latest CRE, facility management, and autonomous building strategies. Mike Petrusky asks Drew about the rapid pace of change in technology and the workplace and how he keeps up by engaging with industry connections while constantly being “a curious nerd”. Drew believes that data governance has become our paramount concern, so he leads his teams with a focus on ensuring data quality and accuracy. When considering new technologies, Drew shares his philosophy of identifying business outcomes rather than just jumping on the latest trends. Artificial intelligence has great potential to impact the built environment, so it's important to ensure the underlying data it learns from is accurate and complete. Mike and Drew agree that we must lead using change management strategies that put humans first, acknowledge our struggles and failures, and encouraging continuous learning and improvement as we seek to be a workplace innovator in our organizations. Connect with Drew on LinkedIn: https://www.linkedin.com/in/drewdepriest/ Learn more about McKesson: https://www.mckesson.com/about-mckesson/ Check out the “On My Way To Work” video series: https://www.youtube.com/playlist?list=PLSkmmkVFvM4E39sM-pNaGhLoG0dkM947o Discover free resources and explore past interviews at: https://eptura.com/discover-more/podcasts/workplace-innovator/ Learn more about Eptura™: https://eptura.com/ Connect with Mike on LinkedIn: https://www.linkedin.com/in/mikepetrusky/  

Join us for the latest episode of RISE Radio, our podcast series that focuses on issues that impact policies, regulations, and challenges faced by health care professionals responsible for quality and revenue, Medicare member acquisition and experience, and/or social determinants of health.Katie Devlin, DHSc, MS, CPHIMS, vice president of interoperability at Cotiviti, returns to RISE Radio and is joined by Adam Gilbert, director of interoperability operations and partnerships at Cotiviti, for this 23-minute episode. They discuss the latest regulatory requirements, what to expect for 2025, challenges, and best practices to implement a robust digital data strategy.About Katie DevlinKatie Devlin, DHSc, MS, CPHIMS, vice president, interoperability, Cotiviti, Inc. is responsible for creating an enterprise-wide health data exchange strategy to address clients' unique business needs while reducing provider abrasion, maintaining regulatory compliance, and optimizing value. She oversees all initiatives related to digital health data acquisition, ingestion, storage, and normalization, including the expansion of Cotiviti's electronic health data networks and strategic partnerships. Drawing on her extensive informatics and health information exchange experience, she is an advocate for ensuring health information is delivered in a way that enhances the member, provider, and payer experience. About Adam GilbertAdam Gilbert, director, interoperability operations and partnerships, works collaboratively with payers, providers, and vendors to increase the use of clinical data exchange. With over 20 years of experience in health care operations and consulting, He is committed to enhancing the health care landscape through effective interoperability strategies and operational excellence. Prior to joining Cotiviti, he held senior management roles at Change Healthcare and McKesson. About CotivitiCotiviti enables health care organizations to deliver better care at lower cost through advanced technology and data analytics, helping to ensure the quality and sustainability of how health care is delivered in the United States. Cotiviti's solutions are a critical foundation for health care payers in their mission to lower health care costs and improve quality through higher performing payment accuracy, quality improvement, risk adjustment, consumer engagement, and network performance management programs. The company also supports the retail industry with data management and recovery audit services that improve business outcomes. 

According to the State of Sales Enablement Report 2024, those who leverage technology to power sales training are 50% more likely to improve quota attainment. So how can you enhance training efficiency and boost rep productivity with a unified platform? Shawnna Sumaoang: Hi, and welcome to the Win-Win podcast. I am your host, Shawnna Sumaoang. Join us as we dive into changing trends in the workplace and how to navigate them successfully. Here to discuss this topic is Amanda Steiner, the director of sales enablement and training at McKesson. Thanks for joining us, Amanda. I’d love for you to tell us about yourself, your background, and your role. Amanda Steiner: Thank you so much for having me. This is so exciting. So a little bit about me. I’ve been with McKesson for just under eight years now. Came into the organization initially as a part of the inside sales team. Loved it, had a great time, eventually moved out to the field and then became a people leader in the sales force. And as I was an individual contributor in this organization, I began to observe a lot of trends that were occurring even outside of my business unit that I think lent itself to opportunities for even an org of our size. To think more strategically about how we’re asking reps to spend their time in order for them to be more successful. And that was sort of the tip of the iceberg, but that drove my interest in enablement and training in general. I happen to have a background in education as far as my schooling. So I thought this was a nice cross-section of interests for me, but have since been leading our sales enablement and training organization for our pharmaceuticals division for McKesson for the last year and a half. SS: Amazing. Well, I know that you’ve also spent, I believe, the majority of your career in the healthcare industry, both in the sales and sales enablement space. Given that experience, what are some of the unique challenges that you would say reps in the healthcare industry face, and how can enablement help overcome those? AS: Healthcare is a very challenging industry. It’s ever-changing. It requires more than just a deep knowledge of the products that you’re selling in the market. It requires a well-rounded understanding of the entire healthcare ecosystem. So, From manufacturer to distributor, to provider, to patient, and all the financial and compliance considerations throughout. That means our sellers are really challenged to be, at any given time, well-informed, agile, and have excellent consultative techniques in their sales approach. So, their tools, resources, and support teams have to be able to rise to meet those challenges. So a strong enablement strategy is a must. If successfully pulled through, enablement’s going to provide the structure, governance, data insights, and innovation that you need in this kind of complex environment to keep sellers informed, marching to the beat of the same drum, and used to continuous learning Overburdening their mindshare. I know that’s a problem for a lot of us in healthcare because there is a change, not just quarterly, not just monthly, but almost daily. And we’re throwing so many things at reps that are in the position of informant to their customers and advocates to their customers as much as they are maintaining the sales relationship. So it’s very challenging, but I am super confident that enablement is the answer even for an organization of this size and complexity. SS: I could not agree more. And Mikesa, you’re responsible for helping with a lot of that continuous learning, including developing and managing the training programs. In your view, what are some of the key building blocks for an effective training program? AS: It’s such a good question. And it’s something that I hear enablers and trainers talk a lot about. But the one thing that I think we can all agree on is there is an old adage in the writing world that you should always begin with the ending in mind. And the same concept applies when you’re building a training program. You can’t manage what you don’t measure. And if you’re not painfully specific about the problems you’re looking to solve, whether it is behavioral, whether it’s tactical, or data-driven, then you’re very seldom going to be able to truly address the problem, and it will just be a superficial solution. I also really recommend having a mixture of KPIs. I think one thing that enablement and training organizations struggle with is telling the story of our impact on the org. Because we’re a nonrevenue generating organization, we have to be able at any given time to tell that story. So the best way to do that is to make sure that you are not only measuring a moment in time where you deliver training and you can look at the sales target results from that date. But you should also be measuring and observing behavioral skills, selling skills, how these things over time have changed in correlation to moments in time when you made process changes, where you implemented training, and you can tell a story around multiple KPIs. I think the last note I’ll make is don’t just check the box on evaluation. Make sure that the way you’re measuring is as targeted as what you’re measuring. So in our organization, we’ve changed our approach on this to requiring teachbacks for tactical knowledge, things like sales process, things like, do you know how to log this thing over here, rather than always defaulting to assessment style evaluation. We also require role plays and stand and delivers for selling skills and this might come as a surprise to some of the listeners, but we hadn’t previously been very intentional about our evaluation mechanism. So, don’t check the box on that. Make sure that you’re thoughtful in how you’re choosing to evaluate the work that you’re putting out into the world. To really be confident that the sales reps are going to be ready to go as soon as you’re done with that effort. SS: I think that is phenomenal advice in terms of kind of the foundational building blocks. I’m curious, what did training look like at your organization before you started leveraging Highspot and how has it evolved since then? AS: I would say that we needed a lot of help with organization of efforts and particularly With making sure that our reps were not overburdened with information in dozens of places, which is where we started. And I think what we’re still working from, as you can imagine, is that takes a lot of time in internal collaboration and intention to get to a point where your points of origin for a sales rep are greatly reduced. I would say that for McKesson, where we started was with multiple business units that operate in very siloed ways. And I think that’s still a struggle for us and a struggle that I think many of your listeners particularly large organizations can relate to. But we didn’t have a common environment for content management that integrated with the CRM that also enabled us to get real-time data on how reps were interacting with this content, consuming it, and sharing it with customers. So we just did not have any kind of closed-loop system. to justify our efforts and also form a more strategic collaborative strategy with marketing, with strategy, with operations. So I would say before Highspot, there was a lot of throwing things at the wall and hoping something stuck. Now, we’re still in the phase of building our critical infrastructure for the business around it, but I am super optimistic based on what we’ve seen already. This is going to provide a launch pad for us. That’s not only promoting our digital literacy in the sales world, especially now that we’re in a much more virtual selling environment but is also going to create the foundation for our support teams, as well as our sellers to sell more intelligently, which I know is what we’re all striving for. If you don’t have a good infrastructure, you don’t have good data. You don’t make informed decisions. SS: I love that philosophy and approach. I think that is some very sound advice on the topic of challenges. What would you say are some of the common pitfalls that organizations might encounter when they’re developing training programs and do you have any advice on how they can avoid them? AS: Yes, too quickly jumping to solutioning. I think that’s something that we all do when we’re super excited to fix a problem. The thing that gets in the way, of course, is ego. We all want to solve the problem and think based on our experience, we have the answer. So we get excited about it, but. What you’ll see, of course, is, uh, you end up in a position where you haven’t really gotten to the bottom of what are driving the surface concerns that you’ve been made aware of. And a lot of the time, You’re going to hear things like, it’s a selling skills issue. They need objection-handling workshops. They need help with our value propositioning. And sometimes that’s true. Sometimes it’s true that it’s a mixture of things. But my question to the listeners would be, do you have a sales methodology problem or do you have a sales process problem? And if you’re not confident in what you’re hearing and its root cause, don’t begin to solution until you get to the bottom of it. SS: I think that is phenomenal advice. And I have to admit, sometimes I feel like I’m guilty of that from time to time. So I think that’s. Amazing advice for our audience. To shift gears just a little bit. I’m curious, how do you foster a culture of continuous learning amongst your sales team and motivate them to want to enhance their skills and knowledge? If you have best practices for driving engagement in your training programs, I think our audience would also learn a lot from you on that front. AS: Yeah, you know, this is still something that we have to work on also. I like to think of it as an art, especially because the way we sell is going to and must continuously evolve. What I’ll say is That you need to meet people where they’re at. So, the best training is one that is quickly consumed and quickly applied. So, why not replicate how people are taking in information today? Um, that’s led us to radically shorten our virtual learnings, opting for mixed modalities like more video content, more job guides, and a focus on the application right away. Rather than just strictly using assessments or throwing a ton of information at people. What ends up happening is, between your information dump, between the assigned corporate HR training everybody has to do in a year, you create training fatigue and a very bad brand. You have to get people excited about training by making it bite-sized and very clear what’s in it for them. Again. So layer knowledge, don’t throw it all out there all at once. Give folks just enough to be excited and go practice right away. So they have a positive impression of learning continuously and they want to keep coming back because it’s working. I heard from a peer, and I thought this was very provocative, that training should be one part teaching. Two-part application. Especially when virtual. You need to drive that engagement. People need to feel like they’re playing an active role in the education. They’re going to remember that far more than anything you assign that may be content robust that you’re super proud of that is just going to cause fatigue and dismissiveness for them. SS: I can see, I can see that. And I like that formulaic approach for sure. When you go to evaluate the success of your training initiatives and kind of the overall sales readiness efforts within McKesson, how are you leveraging data to optimize these programs? AS: I feel like this is the golden egg question for so many sales enablement and training organizations. Data is power. But you can’t get good, reliable data without the infrastructure to collect it in the first place. We had to start doing a lot of foundational work with stakeholders to define sales processes, how we were going to use our CRM, and whether or not we needed to do a data hygiene cleanup in our CRM. But once you’ve established these foundations, you still need multiple KPIs to show trends and a narrative impact. I would use a combination of, you know, your sales target data, your CRM data from the point of training, as well as things like benchmarking surveys on skills from their leaders before and after a training is administered, and how they perform in role plays with a set rubric. Combine these things after the fact to find common trends that eliminate any doubt or suspicion that It wasn’t your work as an enablement and training org that is driving a change because there’s a healthy amount of skepticism because there’s a lot that goes into sales reps achieving their targets and their goals. So you need to be very intentional about what you’re going to measure before you even start your effort and then combine it with this multi-pronged KPI approach to be able to say. There’s undeniably a trend happening here. There was undeniably a shift in what we wanted to see from this point in time and from this effort. And that’s why you can be confident what we’re doing is making a difference. While we’re still building the critical infrastructure around the sales process and our tech stacks for our sales teams, the data we are starting to look at is not only how it’s making a difference in their day-to-day sales targets, but I think new hires, in particular, are a great data set for enablement. You can look at how quickly they’re achieving their first sales, their first closes. You can look at how quickly they’re achieving their first renewals if they’re in a retention-based role. We’re also looking at How they are consuming content in the high spot system, interacting with their customers per the CRM data, and whether or not our stronger sellers are taking this more holistic approach to engagement with their customers. And what can be learned from their approaches to make strategic changes in how we coach and form our training programs. We obviously grade or ask that they grade our training efforts once they go through the program, not just with things like CSAT, but how quickly do you feel you can apply this training right away? So, there are some soft measures as well as hard metrics that we’re working on pulling more regularly, but this is going to be an area where we’re going to have to continue to expand the KPIs we’re dipping into to make the more data-informed changes to our programs over time. SS: I love that. And I love those really concrete examples of things that folks can take advantage of from a data perspective to start to optimize their programs. I’m curious, what are some of the results that you’ve seen in your training and sales readiness efforts? And are there any key wins or notable business outcomes that you’re able to share with us? AS: So since we’ve focused on an enablement infrastructure through getting clear on our processes and our technology stacks, we’ve not only seen substantial adoption of Highspot for more than just our content management, but much more informed conversations are beginning to take place as a result of Shaping the Highspot environment around the sales strategy, the marketing collateral, the go to market approach, their sales playbooks. So we’re still doing a lot of this foundational work, but one example I can give you is a team that got very intentional about this approach last quarter in 90 days alone, increased their time in Highspot by a thousand percent over the previous quarter. And the deals lost decreased by 34%. And their CRM adoption, our CRM is Salesforce, jumped from just under 50 percent to 80 percent in one quarter. So there’s a story to be told there where you can tell it was evident for this team that they understood the core function of their role to the extent that they understood their sales process. They understood how they were going to be using their technology, and how it was going to serve them. Also, critically, that high spot became The core location for their enablement resources and strategic direction. SS: Well, it sounds like you guys have seen some early amazing results as you look ahead, what are some of your goals as you continue to develop your training and enablement strategies at McKesson? AS: Sure. Now that we’ve just about established the critical infrastructure I mentioned before, we’re really continuing to advance towards building our Digital selling literacy, I’ll call it. We are challenging ourselves to get more innovative in how we interact with customers, and how we leverage the information and resources at our disposals to create more compelling. And engaging conversations with our customers that hit more on the mark of the things that they care about. So as part of that effort, we’re developing playbooks through Highspot that will really realize all of the effort we’ve been putting into establishing it as the place for content. Our learning management system is the place where you go to use digital sales rooms and have these other ways of interacting with customers. In a more formulaic approach to saying here is What we advise for optimal results in your sales role. I think playbooks may be the pinnacle use case or a pinnacle use case of Highspot when you get to bring all of those elements together. And we’re confident that if we get it right, we’re not only going to make a huge difference in reducing reps’ administrative burden substantially because today they’re going to a million different places to get all these pieces of collateral information. Advice from our SMEs, et cetera, down to just their CRM and Highspot as their points of origin for their day-to-day. But we’re also confident that now we’re going to get apples-to-apples data amongst our sales teams to begin selling much more intelligently. We’ve never brought our different business units into a system like this to speak the same platform language in this manner. And so I’m really excited about the opportunities to bring this together. Level of information up to our very senior stakeholders to begin to show them a picture of their talent in sales in a completely new way. SS: I love that. Amanda, last question for you. What advice would you give to other healthcare organizations hoping to enhance their training efficiency and try to really boost rep productivity? AS: Be intentional about your enablement strategy within your organization. Our industries are very complex. As a result, we have a tendency to staff in silos, where gaps are initially observed, instead of taking a step back for a more strategic approach functionally. Yes, your customers and product lines may vary across the industry. Your large organization or very complex businesses, but enablement is an infrastructural and strategic approach meant to keep you agile and informed by data and empowered to make bold, innovative changes where needed. So don’t throw something at it. Ask yourself, is this a function of what enablement could carry through? If I had an infrastructure to support a need, even before a need is known. I think that’s really where I’ve seen organizations of this size and within the healthcare landscape struggle. There are so many different avenues of this business that we are trying to solve at the same time. That we end up creating these enormous silos and collaboration challenges. I know collaboration for us is something that continuously comes up in our employee opinion surveys because it is very challenging to reach across the aisle when we’ve been stood up to support very niche needs. That is still critical, but what kind of glue do we need in between these businesses to make sure that we’re agile across the business to make sure that we’re solving for this functional need and not just the niche SME expertise that yes, you must also have. SS: Amanda, phenomenal advice. Thank you so much for joining our podcast today. I really learned a lot from you. AS: Thank you so much for having me. This was a blast. It’s been an honor to be on. I really appreciate it. SS: To our audience, thank you for listening to this episode of the Win-Win Podcast. Be sure to tune in next time for more insights on how you can maximize enablement success with Highspot.

We know you're juggling countless responsibilities and barely have a moment to breathe, let alone think about marketing. But here's the truth: marketing isn't just another task on your to-do list—it's a lifeline of your business. In this episode, part 1 of a 2 part series on marketing, we dive straight into actionable marketing strategies tailored specifically for independent pharmacy owners like you. Discover how effective marketing can transform your business, driving more foot traffic, increasing customer loyalty, and boosting your bottom line. From leveraging social media to building a community presence, we break down the essentials without the fluff. Why should you care about marketing? Because it's the key to standing out in a crowded market. It's the tool that turns first-time visitors into loyal customers. It's the difference between just getting by and truly thriving. By investing just a few minutes of your time with us, you'll gain valuable insights that can translate into real-world results.Hear about jaw-dropping success stories, such as a pharmacy that booked 400 flu shot appointments in a single day and discover how to engage patients without overwhelming your staff. Make marketing a priority and watch your pharmacy grow. Tune in and take the first step towards a more prosperous business today. HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson, Health MartGuestsAJ AsgariCEO & FounderDrugstore2DoorResourcesLearn more about the Community Health Worker training program, the requirements for participation and the application process here. [https://www.ceimpact.com/chw/]Learn more about Drugstore2Door on the Health Mart Perks page on myHealthMart.com [https://my.healthmart.com/purchasingAdvantage.htm] or at https://drugstore2door.biz/The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

In past episodes of The TechLink Health Podcast, we've explored how digital transformation in healthcare and life sciences is driving innovation for emerging health-tech and medical devices, from heart-health and neuro-tech to AI and machine learning. A key challenge in scaling these technologies lies in adoption and discoverability, which can be addressed by making them more accessible and remotely deployable on a global scale. As wearables and connected devices like IoHT and IoMT shape the future of treatment and prevention, their market is set to exceed $400 billion by 2030. In today's episode, we dive into neuro-tech, wearables, and the innovation of photobiomodulation technology. Here to talk about all of this and more, is Peter Adams, a commercialization consultant and senior executive with experience building tech-focused organizations in global markets. Peter has worked with companies like Intel, McKesson, and MaRS Discovery District. He's now Vice President of Commercialization at ⁠Vielight⁠, which uses neuroscience and photobiomodulation to enhance brain health. Vielight's research has shown improvements in cognition, memory, and mood, and their technology is recognized by organizations like the U.S. Department of Veterans Affairs for treating traumatic brain injuries. Listen in with us as explore the innovation of photobiomodulation and its many use cases ranging from enhanced neurofeedback to improved athletic performance to impacts on experiential levels of meditation. Other insights range from the potential of AI to detect new biomarkers yet to be discovered, to the emerging opportunity to rethink vital signs using real-time data from smartphones, to how many devices have no contraindications with medications and are increasingly a viable treatment alternative. Also, how are consumers driving the adoption of new technologies that are gradually being trusted by clinicians? For more details visit TechLink Health ⁠on the web⁠ or connect with Peter on ⁠LinkedIn⁠. This episode was hosted by Dr. Sarah Samaan.

“I'm madly passionate about procurement because I think it's a hidden gem of the corporate world, and it's a magical field for problem solvers.” - Natasha Gurevich, Founder and CEO of Candor Procurement Natasha Gurevich, Founder and CEO of Candor Procurement, has a long track record of procurement leadership under her belt. Most recently, she was the first Chief Procurement Officer at Nike, and, before that, VP of Global Procurement at Salesforce. She has also enjoyed procurement leadership roles at McKesson, Paypal, Gap, and Visa. In this episode, Philip Ideson talks with Natasha about her journey to becoming one of procurement's most well-known change agents and how her decades of experience in leadership roles have shaped her approach to driving change at scale.  Natasha shares her perspectives on: How to create change without causing too much disruption, fear, or resistance Adopting a specific, repeatable methodology to change in order to balance wider business goals with individual needs and concerns The ways procurement needs to evolve and improve, starting with a recognition that category management will be the #1 driving factor for success in the future Links: Natasha Gurevich on LinkedIn Subscribe to This Week in Procurement Subscribe to the AOP YouTube channel

Fortune 30 C-level executive Maria Lensing tells us about the many rules—both corporate and cultural—she's broken to advance her career. This Latina powerhouse from Peru has been a leader at Walgreens, McKesson and AT&T, and is now the Global CIO & CTO at Sorenson Communications. In this super candid and honest conversation celebrating Hispanic Heritage Month, we chat with Maria about the realities of being a multicultural woman in corporate America. Maria points out all the voices around us—the ones we should listen to and how to work through all the other noise. “The biggest element of success is what your mind thinks and the influences that you let in,” says Maria. Passionate about advancing women in the workplace, Maria shares the #1 thing she's learned from her corporate climb, how she's bucked the traditional family and the three questions she asks herself when making big career moves.Theme: Changing Course Without HesitationEpisode Highlights:Don't let others define what success looks like for youHow to make big career decisionsDefining failureBreaking cultural rulesWhat leaders can do to advance multicultural womenMaria's Bio: Maria Lensing is the Global Chief Information Officer & Chief Technology Officer at Sorenson Communications. Prior, she was the Chief Strategy and Transformation Officer at Walgreens Boots Alliance. Before that, Maria was the CTO at McKesson. And prior to McKesson, Maria spent 11 years at AT&T in both technical and business leadership roles. She was VP of Healthcare Solutions and she was also Chief of Staff for the Chief Executive Officer of AT&T Business.Maria has a Bachelor of Science in Electrical Engineering and a Master of Science in Engineering Management from Christian Brothers University (CBU). She completed her Executive Education at Harvard Business School. She is also an independent director at Sorenson Communications and a board director for the Hispanic IT Executive Council (HITEC). Maria is passionate about STEM opportunities for youth, women in leadership and promoting minority inclusion in the executive ranks. She has received a lot of recognition, including the 2023 Top 100 Latinas by Latino Leaders Magazine and HITEC 100 Leaders for 2022, 2021 and 2020. Connect with us on our social media: Instagram and LinkedInMore from Alisa Manjarrez: Instagram and LinkedInMore from Courtney Copelin: Instagram and LinkedInMore from Dr. Merary Simeon: Instagram and LinkedInLearn more at www.whatrulespodcast.com.

In this episode, Scott Becker discusses five stocks that faced significant declines, including Tempus AI, Coinbase, Tesla, McKesson, and Zimmer Biomet, each reflecting key trends in healthcare, AI, and the broader market. He also shares gratitude for the podcast's top ranking on Apple Business News.

NFL owners approved private equity firms investing in teams this season, we talk about the soaring franchise valuations and hear a player's perspective on money. (00:21) Emily Flippen and Matt Argersinger discuss: - Weak jobs data, inverted yield curve, and whether the market will cheer a larger rate cut this fall. - Why private equity is interested in Smartsheet and putting money into NFL franchises this season. - The latest earnings updates from: Toro, Docusign, and ABM Industries (19:11) Brandon Copeland played ten years in the NFL – now the linebacker is an ivy league professor, author, and advocate for college athletes. Copeland talks through his book Your Money Playbook, the realities of an NFL contract, and how some college players are finally getting their due. (34:45) Emily and Matt break down two stocks on their radar: McKesson and AO Smith. Stocks discussed: SMAR, DOCU, TTC, ABM, MCK, AOS Host: Dylan Lewis Guests: Emily Flippen, Matt Argersinger Engineers: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Scott Becker discusses the latest market downturn, the muted August jobs report, and key movements in stocks like Tesla, Dollar Tree, and McKesson. He also highlights upcoming speaking engagements and exciting news about the podcast’s top ranking on Apple Business News.

Tim Ulbrich interviews Emmanuel Ayanjoke, PharmD, on his journey to opening an independent pharmacy in Avondale, tackling challenges with vision, risk-taking, and community care. This episode is brought to you by First Horizon. Summary In this inspiring episode, Tim Ulbrich interviews Emmanuel Ayanjoke, R.Ph, PharmD, MBA, a third-generation pharmacist with a passion for community care. Emmanuel shares his remarkable journey to opening an independent pharmacy in Avondale, Cincinnati. Driven by a desire to make a difference, he pursued a pain management and palliative care fellowship, gaining invaluable entrepreneurial experience along the way. Through the support of Project Oasis, a McKesson initiative aimed at addressing pharmacy deserts, Emmanuel was able to turn his vision into reality. Despite facing significant financial challenges, including high student loan debt, Emmanuel underscores the importance of calculated risk-taking and the power of strong relationships. Emmanuel offers insights into the future of independent pharmacy and how he has strategically aligned his personal and business financial plans to achieve his goals. This episode is a must-listen for anyone interested in the evolving landscape of independent pharmacy and the bold steps required to succeed. About Today's Guest Dr. Emmanuel (Manny) Ayanjoke, R.Ph, PharmD, MBA is the proud owner of Altev Community Pharmacy in Cincinnati, Ohio. A graduate of University of Toledo College of Pharmacy, Dr. Manny has spent over 5 years serving various communities as a dedicated pharmacist. Before opening Altev, he worked at Ziks Family Pharmacy, honing his skills, and understanding the vital role of pharmacists in community health. His work as a clinical pharmacist at Ziks had notable success and he was featured as a keynote panelist at the American Pharmacist Association (APhA) 2022 conference. Alongside his clinical role at ZIKS Family Pharmacy, Dr Manny completed a fellowship in pain management and palliative care fellow at Cedarville University where he engaged in teaching, research, patient care, as well as creation of innovative ways to advance pharmacy practice. Mentioned on the Show Emmanuel Ayanjoke LinkedIn Altev Community Pharmacy Project Oasis NCPA Survey  The Dip by Seth Godin Tim Ulbrich on LinkedIn YFP on Instagram YFP Facebook Group Your Financial Pharmacist YFP Disclaimer YFP Newsletter

Are you ready to revolutionize your business with digital transformation?In this episode of The Business Ownership Podcast I interviewed Steve Russell. Steve, the visionary CEO of Upstart 13, embarked on a transformative journey that reshaped the outsourcing industry. Dissatisfied with the status quo, he boldly left his prestigious role at McKesson (NYSE: MCK).Before founding Upstart 13, Steve oversaw the Patient Services Business Unit at CoverMyMeds, a healthcare unicorn within the McKesson technology ecosystem. His expertise extended to managing Business Operations and Services Teams at PROS Inc. (NYSE: PRO).Determined to create an outsourcing company unlike any other, Steve scoured for top-tier talent, cultivating a culture and ethos rivalling the most esteemed US companies. His approach centered on empowering individuals, creating a lasting impact, and prioritizing a "People First" mentality. As a Berkeley Executive Leader with over two decades in the software industry, Steve's academic prowess, including a Master's of Science in Information Systems Management from The University of Liverpool and a Bachelor of Science in Mechanical Design Engineering.Today, Upstart 13 is a testament to Steve's bold vision and unwavering dedication. Curious how custom software can skyrocket your business growth? Check this out!Show Links:Upstart 13 Website: https://upstart13.com/contact-us/Steve Russel on LinkedIn: https://www.linkedin.com/in/steve--russell/Book a call with Michelle: https://go.appointmentcore.com/book/IcFD4cGJoin our Facebook group for business owners to get help or help other business owners!The Business Ownership Group - Secrets to Scaling: https://www.facebook.com/groups/businessownershipsecretstoscalingLooking to scale your business? Get free gifts here to help you on your way: https://www.awarenessstrategies.com/

James talks to Mo about the supreme court's decision not to hear the McKesson case, what it really means for protest, and wise legal strategy for protesters in a year of election and genocide. https://harvard.turtl.co/story/protect-your-people/page/1  https://ssd.eff.org  Https://NLG.org See omnystudio.com/listener for privacy information.